Average Co-Inventor Count = 3.12
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aimm Therapeutics B.v. (13 from 22 patents)
2. Academisch Medisch Centrum Bij De Universiteit Van Amsterdam (6 from 11 patents)
3. Medimmune Limited (4 from 541 patents)
4. Kling Biotherapeutics B.v. (4 from 4 patents)
5. Cancer Research Technology Limited (2 from 262 patents)
6. Stichting Het Nederlands Kanker Instituut-antoni Van Leeuwenhoek Ziekenhuis (1 from 12 patents)
7. Academish Medisch Centrum Bij De Universiteit Van Amsterdam (1 from 1 patent)
25 patents:
1. 12084681 - Ex vivo antibody production
2. 11999793 - Therapeutic anti-CD9 antibody
3. 11629200 - Means and methods for counteracting myeloproliferative or lymphoproliferative disorders
4. 11524989 - AML antigens and uses thereof
5. 11136407 - Therapeutic anti-CD9 antibody
6. 10774308 - Means and methods for influencing the stability of cells
7. 10730931 - RSV-specific binding molecules and means for producing them
8. 10690658 - Means and methods for determining T cell recognition
9. 10556963 - Means and methods for counteracting myeloproliferative or lymphoproliferative disorders
10. 10344076 - Means and methods for producing high affinity antibodies
11. 10273454 - Means and methods for influencing the stability of antibody producing cells
12. 10077427 - Means and methods for influencing the stability of cells
13. 10059757 - RSV-specific binding molecules and means for producing them
14. 9969795 - Means and methods for producing high affinity antibodies
15. 9822339 - Means and methods for influencing the stability of antibody producing cells